Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 235,000 | 214,000 | 310,000 | 74,000 | 193,000 |
| Other Working Capital | -487,000 | -201,000 | -789,000 | 5,350,000 | -804,000 |
| Other Operating Activity | 2,767,000 | 1,376,000 | 1,142,000 | -1,305,000 | 2,688,000 |
| Operating Cash Flow | $2,515,000 | $1,389,000 | $663,000 | $4,119,000 | $2,077,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -268,000 | -216,000 | -215,000 | -404,000 | -253,000 |
| Net Acquisitions | -132,000 | -9,000 | -3,686,000 | 16,000 | -277,000 |
| Purchase Sale Intangibles | -99,000 | -352,000 | -74,000 | -42,000 | 12,000 |
| Other Investing Activity | 107,000 | 17,000 | 31,000 | 108,000 | 153,000 |
| Investing Cash Flow | $-468,000 | $-564,000 | $-3,952,000 | $-413,000 | $-507,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -2,912,000 | 800,000 | 2,209,000 | -1,999,000 | -435,000 |
| Debt Issued | 2,219,000 | -19,000 | 2,622,000 | 48,000 | 42,000 |
| Common Stock Issued | 8,000 | 6,000 | 27,000 | 43,000 | 8,000 |
| Dividend Paid | -940,000 | -1,137,000 | -935,000 | -934,000 | -934,000 |
| Other Financing Activity | -225,000 | -542,000 | -262,000 | -404,000 | -351,000 |
| Financing Cash Flow | $-1,850,000 | $-892,000 | $3,661,000 | $-3,246,000 | $-1,670,000 |
| Exchange Rate Effect | 6,000 | 54,000 | -40,000 | 40,000 | 2,000 |
| Beginning Cash Position | 4,406,000 | 4,419,000 | 4,087,000 | 3,587,000 | 3,685,000 |
| End Cash Position | 4,609,000 | 4,406,000 | 4,419,000 | 4,087,000 | 3,587,000 |
| Net Cash Flow | $197,000 | $-67,000 | $372,000 | $460,000 | $-100,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,515,000 | 1,389,000 | 663,000 | 4,119,000 | 2,077,000 |
| Capital Expenditure | -459,000 | -635,000 | -304,000 | -635,000 | -431,000 |
| Free Cash Flow | 2,056,000 | 754,000 | 359,000 | 3,484,000 | 1,646,000 |